[FATE] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
15-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -27.53%
YoY- -20.88%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 1,027 1,026 1,026 1,027 1,027 1,026 1,027 0.00%
PBT -12,497 -10,684 -9,645 -10,126 -7,940 -8,737 -8,408 30.14%
Tax -131 378 137 111 -160 37 31 -
NP -12,497 -10,684 -9,645 -10,126 -7,940 -8,737 -8,408 30.14%
Tax Rate - - - - - - - -
Total Cost 13,524 11,710 10,671 11,153 8,967 9,763 9,435 27.04%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -1,216.85 -1,041.33 -940.06 -985.98 -773.13 -851.56 -818.70 30.14%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -0.29 -0.26 -0.23 -0.24 -0.21 -0.27 -0.29 0.00%
EPS Diluted -0.29 -0.26 -0.23 -0.24 -0.21 -0.27 -0.29 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.